EXAM
Exam Solution ms
ONCC Tests (OCN Care Continuum) 2026 A+ GRADE AS
ms ms ms ms ms ms ms ms
SURED COMPLETE SOLUTIONS AND VERIFIED ANSWER ms ms ms ms ms
S (55F02)ms
QUESTION 1 ms
Which of the following is an advantage of an implanted vascular access device over a t
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
unneled central venous catheter? Decreased risk of infection Short-
ms ms ms ms ms ms ms ms
term use Low cost of insertion Unlimited ability to access
ms ms ms ms ms ms ms ms ms
ANSWER
Decreased risk of infection Answer: Implanted ports have a lower risk of infection than tunneled cen
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
tral venous catheters. Reference: Camp-
ms ms ms ms
Sorrell, D., & Matey, L. (Eds.). (2017). Access device standards of practice for oncology nursing. Pitts
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
burgh, PA: Oncology Nursing Society, p. 67.
ms ms ms ms ms ms
QUESTION 2 ms
The nurse teaches a patient that the purpose of a living will is to: establish the patien
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
t's desires for care prior to a life-
ms ms ms ms ms ms ms
threatening illness. make final decisions regarding treatment until disease progression
ms ms ms ms ms ms ms ms ms
. acknowledge the risks and limitations of recommended therapies. appoint a surrogat
ms ms ms ms ms ms ms ms ms ms ms
e to make medical decisions.
ms ms ms ms
ANSWER
establish the patient's desires for care prior to a life-
ms ms ms ms ms ms ms ms ms
threatening illness. Answer: Living wills are designed to determine the care that a patient is agreeab
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
le to receive or not receive in the event of a terminal illness. Reference: Eggert, J. (Ed.). (2017). Can
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
cer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society, p. 655(t).
ms ms ms ms ms ms ms ms ms ms
QUESTION 3 ms
Within which timeframe will chemotherapy-
ms ms ms ms
induced alopecia normally begin after receiving a first treatment? 2 weeks 24 hours 1
ms ms ms ms ms ms ms ms ms ms ms ms ms m
month 3 months
s ms ms
, ANSWER
2 weeks Answer: Hair loss from chemotherapy usually begins two weeks after beginning treatment.
ms ms ms ms ms ms ms ms ms ms ms ms ms ms
Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society,
ms ms ms ms ms ms ms ms ms ms ms ms ms ms
p. 360.
ms
QUESTION 4 ms
A patient with breast cancer who received cyclophospamide five years ago reports a n
ms ms ms ms ms ms ms ms ms ms ms ms ms
ew onset of bruising and fatigue. The nurse suspects: a secondary leukemia. liver failu
ms ms ms ms ms ms ms ms ms ms ms ms ms
re. leukoencephalopathy. cardiomyopathy.
ms ms
ANSWER
a secondary leukemia. Answer: The risk of secondary leukemia increases with the use of alkylating a
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
gents. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy
ms ms ms ms ms ms ms ms ms ms ms ms ms
guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p.
ms ms ms ms ms ms ms ms ms ms ms ms ms ms
446(t).
QUESTION 5 ms
A patient with ovarian cancer is most likely to be diagnosed with which of the followi
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ng secondary malignancies? Ocular melanoma Leiomyosarcoma Gastric carcinoma Hod
ms ms ms ms ms ms ms ms
gkin lymphoma ms
ANSWER
Ocular melanoma Answer: A patient with ovarian cancer is at risk for the development of a seconda
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ry melanoma of the eye. Reference: Yarbro, C.H., Wujcik, D., & Gobel, B.H. (Eds.). (2018). Cancer nurs
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ing: Principles and practice (8th ed.). Burlington, MA: Jones and Bartlett, p. 2036(t).
ms ms ms ms ms ms ms ms ms ms ms ms
QUESTION 6 ms
Which of the following risk factors will most significantly increase the risk of developi
ms ms ms ms ms ms ms ms ms ms ms ms ms
ng breast cancer? Mother diagnosed before age 60 Menopause occuring at age 54 First
ms ms ms ms ms ms ms ms ms ms ms ms ms
pregnancy at age 31 Menarche at age 13
ms ms ms ms ms ms ms ms
ANSWER
Mother diagnosed before age 60 Answer: Having a mother who was diagnosed with breast cancer b
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
efore the age of 60 years has an associated relative risk of 2 to 4 times of those without this risk fa
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ctor. Reference: Newton, S., Hickey, M., & Marrs, J. (2017). Mosby's oncology nursing advisor: A com
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
prehensive guide to clinical practice (2nd ed.). St. Louis, MO: Elsevier Mosby, p. 4.
ms ms ms ms ms ms ms ms ms ms ms ms ms
QUESTION 7 ms
The nurse teaches a patient that the survivorship care plan is used to: provide clear d
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
irection for ongoing care and surveillance following treatment. provide instructions to
ms ms ms ms ms ms ms ms ms ms m
Exam Solution ms
ONCC Tests (OCN Care Continuum) 2026 A+ GRADE AS
ms ms ms ms ms ms ms ms
SURED COMPLETE SOLUTIONS AND VERIFIED ANSWER ms ms ms ms ms
S (55F02)ms
QUESTION 1 ms
Which of the following is an advantage of an implanted vascular access device over a t
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
unneled central venous catheter? Decreased risk of infection Short-
ms ms ms ms ms ms ms ms
term use Low cost of insertion Unlimited ability to access
ms ms ms ms ms ms ms ms ms
ANSWER
Decreased risk of infection Answer: Implanted ports have a lower risk of infection than tunneled cen
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
tral venous catheters. Reference: Camp-
ms ms ms ms
Sorrell, D., & Matey, L. (Eds.). (2017). Access device standards of practice for oncology nursing. Pitts
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
burgh, PA: Oncology Nursing Society, p. 67.
ms ms ms ms ms ms
QUESTION 2 ms
The nurse teaches a patient that the purpose of a living will is to: establish the patien
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
t's desires for care prior to a life-
ms ms ms ms ms ms ms
threatening illness. make final decisions regarding treatment until disease progression
ms ms ms ms ms ms ms ms ms
. acknowledge the risks and limitations of recommended therapies. appoint a surrogat
ms ms ms ms ms ms ms ms ms ms ms
e to make medical decisions.
ms ms ms ms
ANSWER
establish the patient's desires for care prior to a life-
ms ms ms ms ms ms ms ms ms
threatening illness. Answer: Living wills are designed to determine the care that a patient is agreeab
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
le to receive or not receive in the event of a terminal illness. Reference: Eggert, J. (Ed.). (2017). Can
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
cer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society, p. 655(t).
ms ms ms ms ms ms ms ms ms ms
QUESTION 3 ms
Within which timeframe will chemotherapy-
ms ms ms ms
induced alopecia normally begin after receiving a first treatment? 2 weeks 24 hours 1
ms ms ms ms ms ms ms ms ms ms ms ms ms m
month 3 months
s ms ms
, ANSWER
2 weeks Answer: Hair loss from chemotherapy usually begins two weeks after beginning treatment.
ms ms ms ms ms ms ms ms ms ms ms ms ms ms
Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society,
ms ms ms ms ms ms ms ms ms ms ms ms ms ms
p. 360.
ms
QUESTION 4 ms
A patient with breast cancer who received cyclophospamide five years ago reports a n
ms ms ms ms ms ms ms ms ms ms ms ms ms
ew onset of bruising and fatigue. The nurse suspects: a secondary leukemia. liver failu
ms ms ms ms ms ms ms ms ms ms ms ms ms
re. leukoencephalopathy. cardiomyopathy.
ms ms
ANSWER
a secondary leukemia. Answer: The risk of secondary leukemia increases with the use of alkylating a
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
gents. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy
ms ms ms ms ms ms ms ms ms ms ms ms ms
guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p.
ms ms ms ms ms ms ms ms ms ms ms ms ms ms
446(t).
QUESTION 5 ms
A patient with ovarian cancer is most likely to be diagnosed with which of the followi
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ng secondary malignancies? Ocular melanoma Leiomyosarcoma Gastric carcinoma Hod
ms ms ms ms ms ms ms ms
gkin lymphoma ms
ANSWER
Ocular melanoma Answer: A patient with ovarian cancer is at risk for the development of a seconda
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ry melanoma of the eye. Reference: Yarbro, C.H., Wujcik, D., & Gobel, B.H. (Eds.). (2018). Cancer nurs
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ing: Principles and practice (8th ed.). Burlington, MA: Jones and Bartlett, p. 2036(t).
ms ms ms ms ms ms ms ms ms ms ms ms
QUESTION 6 ms
Which of the following risk factors will most significantly increase the risk of developi
ms ms ms ms ms ms ms ms ms ms ms ms ms
ng breast cancer? Mother diagnosed before age 60 Menopause occuring at age 54 First
ms ms ms ms ms ms ms ms ms ms ms ms ms
pregnancy at age 31 Menarche at age 13
ms ms ms ms ms ms ms ms
ANSWER
Mother diagnosed before age 60 Answer: Having a mother who was diagnosed with breast cancer b
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
efore the age of 60 years has an associated relative risk of 2 to 4 times of those without this risk fa
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
ctor. Reference: Newton, S., Hickey, M., & Marrs, J. (2017). Mosby's oncology nursing advisor: A com
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
prehensive guide to clinical practice (2nd ed.). St. Louis, MO: Elsevier Mosby, p. 4.
ms ms ms ms ms ms ms ms ms ms ms ms ms
QUESTION 7 ms
The nurse teaches a patient that the survivorship care plan is used to: provide clear d
ms ms ms ms ms ms ms ms ms ms ms ms ms ms ms
irection for ongoing care and surveillance following treatment. provide instructions to
ms ms ms ms ms ms ms ms ms ms m